Young-Taeg Sul
David H. Kwon
Byung-Soo Kang
Se-Jung Oh
Carina Johansson
Experimental evidence for interfacial
biochemical bonding in osseointegrated
titanium implants
Authors’ affiliations:
Young-Taeg Sul, David H. Kwon, Byung-Soo Kang,
Department of Biomaterials, Institute for Clinical
Sciences, Sahlgrenska Academy at University of
Gothenburg, Sweden
Young-Taeg Sul, Institute for Clinical Dental
Research, Korea University, Seoul, Korea
David H. Kwon, U.S. Army Advanced Education
Program in General Dentistry, Fort Bragg, NC, USA
Se-Jung Oh, Department of Physics and
Astronomy, Seoul National University, Seoul,
Korea
Carina Johansson, Department of Prosthodontics/
Dental Materials Science, Institute of Odontology,
Sahlgrenska Academy, University of Gothenburg,
Sweden
Corresponding author:
Associate Professor Young-Taeg Sul
Department of Biomaterials
Institute for Clinical Sciences at Sahlgrenska
Academy at University of Gothenburg
Arvid Wallgrens Backe 20
Box 412, SE 413 46
Gothenburg, Sweden
Tel.: +46 31 786 2969
Fax: +46 31 786 2941
e-mail: young-taeg.sul@biomaterials.gu.se
Key words: biochemical bonding theory, bone and titanium implant interface, osseointegra-
tion mechanism, surface chemistry and topography
Abstract
Objectives: (i) To identify and quantify an interfacial biochemical bond and the bonding strength
of osseointegrated implants with bioactive titanium oxide chemistry, ATiOxB (A, metal cations;
TiO
x
, titanium oxides/hydroxides; B, non-metal anions) and (ii) to provide quantitative evidence for
the biochemical bond theory of osseointegration proposed by Sul et al. for description and
explanation of why and how the implants with ATiO
x
B surface oxide chemistry may exhibit a
significantly stronger bone response, in spite of the fact that the roughness values approached
zero, or were equivalent to or significantly lower than those of the control implants.
Materials and methods: We applied a newly developed biochemical bond measurement (BBM)
method to model implant surfaces that were “perfectly” smooth nanotopography near-zero
roughness as the constant parameter, and used the bioactive surface chemistry of titanium oxide,
ATiO
x
B chemistry as a variable parameter in rabbit tibiae for 10 weeks. In this manner, we
determined an interfacial biochemical bond and quantified its bonding strength.
Results: The increase in biochemical bond strengths of the test implant relative to the control
implant was determined to be 0.018 (±0.008) MPa (0.031 vs 0.021 MPa, n = 10) for tensile strength
and 8.9 (±6.1) Ncm (33.0 vs 24.1 Ncm, n = 10) for removal torque. Tensile and removal torque show
strong correlation in the Pearson test (r = 0.901, P 0.001). In addition, histomorphometric
measurements including bone-to-metal-contact (BMC, P = 0.007), bone area and newly formed
bone showed significant increases in the mean values for ATiO
x
B chemistry (P = 0.007, n = 10).
Biochemical bond theory states that the surface oxide chemistry, ATiO
x
B must have more electrical
and chemical molecular polarity that fractionally charges the surfaces denoted as d
+
and d
and
leads to electrostatic and electrodynamic interactions with the bone healing cascade, eventually
leading to the formation of biochemical bonding at the bone/implant interface.
Conclusions: The present study has provided quantitative evidence for biochemical bond theory of
osseointegration of implants with bioactive surface oxide chemistry, ATiO
x
B. The theory of
biochemical bonds may provide a scientific rationale pertinent to recent emerging trends and
technologies for surface chemistry modifications of implants.
Research on biochemical bonds of osseointe-
gration of metallic implants is a very difficult
scientific challenge and is lacking in the lit-
erature. Since the first introduction of osseo-
integration by Bra ˚ nemark and his co-workers
(Branemark et al. 1969) in 1969, osseointegra-
tion has become a highly viable and predict-
able treatment modality in modern implant
dentistry. However, many unanswered ques-
tions remain regarding in vivo osseointegra-
tion mechanisms that regulate the bone
response to the surface property variables
from the micro to nano-scale. It is widely
believed that osseointegration through bio-
mechanical interlocking or interdigitation is
established as the bone grows into surface
irregularities over time and is stabilised by
the dynamic regulation of bone modelling/
remodelling.
A direct chemical bonding of bioactive
glass-ceramic materials to bone and muscle
was reported by Hench et al. in 1973 (Hench
& Paschall 1973). However, such materials
and their coatings are of limited use in load-
bearing implants due to their poor mechani-
cal properties (Hench 1998). Evidence for the
chemical bonding theory of bioglasses and
bioglass-ceramics was provided based on
Date:
Accepted 18 September 2011
To cite this article:
Sul Y-TH. Kwon D, Kang B-S, Oh S-J, Johansson C.
Experimental evidence for interfacial biochemical bonding in
osseointegrated titanium implants.
Clin. Oral Impl. Res. 00, 2011, 1–12
doi: 10.1111/j.1600-0501.2011.02355.x
© 2011 John Wiley & Sons A/S 1